Allergy, Asthma and Immunology Division Director

Childrens Mercy Hospital   •  

Kansas City, MO

Industry: Patient Care


Not Specified years

Posted 415 days ago

Children's Mercy Kansas City and the University of Missouri – Kansas City School of Medicine seek an innovative, dynamic and energetic leader to serve as the Division Director of Allergy, Asthma and Immunology. The successful candidate will lead the division into an exciting new era where our nationally recognized excellence as clinicians and educators will be complemented by an increased emphasis on cutting-edge research.


Candidates must have a record of health care leadership, national recognition, exemplary academic accomplishments and superb interpersonal skills. They must be board certified in allergy and immunology, and hold the rank of associate professor or professor. Academic appointments are through the University of Missouri – Kansas City School of Medicine. An opportunity for a joint appointment at the University of Kansas School of Medicine also exists.


The division director will be responsible for leading all allergy, asthma and immunology clinical programs, resident and fellow education, and growing the quality improvement and research base of the division. They will also be expected to assume a leading role in faculty development. Our clinical team is comprised of 11 physicians, four fellows-in-training, three nurse practitioners, and a large ancillary staff, with consideration for expansion as part of the division director's vision. In addition, our research team is comprised of three PhDs, four research coordinators and three research assistants.


The division fosters a collaborative research environment characterized by projects that span multiple subspecialties and range in scope from basic to clinical and applied research. Members of our faculty are recipients of extramural research funding from NIH, EPA and HUD. The division has an active clinical pharmacology research program as part of our institution's nationally recognized pharmacology program, and participates in industry sponsored clinical trials from phase I through phase IV. We are also one of 22 Centers of Excellence in the FARE Program, which aims to advance research and elevate quality of care for individuals with food allergies. In the areas of translational research and patient care, the division regularly collaborates with the Center for Pediatric Genomic Medicine at Children's Mercy to identify genetic determinants of immunodeficiency disorders, and interfaces with BMT, Hematology, Rheumatology, Clinical Genetics, Infectious Diseases and other specialties to address the needs of the complex patient population cared for by our division.